Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bachir

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Annals of Hematology|April 22, 2008
Fat emboli unleashed: an exceptional etiology of encephalitis in sickle cell diseaseA Loupy, J P Laissy, I Klein, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Fate of alpha-hemoglobin chains and erythrocyte defects in beta-thalassemiaP Rouyer-Fessard, M D Scott, K Leroy-Viard, et al.
Haematologica|December 7, 2007
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell diseaseF Noizat-Pirenne, D Bachir, P Chadebech, et al.
Blood|March 10, 2001
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilationL Belhassen, G Pelle, S Sediame, et al.
British Journal of Haematology|June 14, 2001
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiationC M Rodrigue, N Arous, D Bachir, et al.
The Journal of Clinical Investigation|October 6, 1997
Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell diseaseL De Franceschi, D Bachir, F Galacteros, et al.
La Revue De Medecine Interne|January 1, 1997
[Prevention and treatment of erectile disorders in sickle cell disease]D Bachir, R Virag, K Lee, et al.
American Journal of Hematology|September 2, 1998
Genetic and hematological studies in a group of 114 adult patients with SC sickle cell diseaseK Lee, C Préhu, G Mérault, et al.
Blood|August 9, 2001
The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemiaK Lee, P Gane, F Roudot-Thoraval, et al.
Blood|January 1, 1985
The heterozygous form of 4.1(-) hereditary elliptocytosis [the 4.1(-) trait]N Alloisio, L Morlé, E Dorléac, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Annals of Hematology|April 22, 2008
Fat emboli unleashed: an exceptional etiology of encephalitis in sickle cell diseaseA Loupy, J P Laissy, I Klein, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Fate of alpha-hemoglobin chains and erythrocyte defects in beta-thalassemiaP Rouyer-Fessard, M D Scott, K Leroy-Viard, et al.
Haematologica|December 7, 2007
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell diseaseF Noizat-Pirenne, D Bachir, P Chadebech, et al.
Blood|March 10, 2001
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilationL Belhassen, G Pelle, S Sediame, et al.
British Journal of Haematology|June 14, 2001
Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiationC M Rodrigue, N Arous, D Bachir, et al.
The Journal of Clinical Investigation|October 6, 1997
Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell diseaseL De Franceschi, D Bachir, F Galacteros, et al.
La Revue De Medecine Interne|January 1, 1997
[Prevention and treatment of erectile disorders in sickle cell disease]D Bachir, R Virag, K Lee, et al.
American Journal of Hematology|September 2, 1998
Genetic and hematological studies in a group of 114 adult patients with SC sickle cell diseaseK Lee, C Préhu, G Mérault, et al.
Blood|August 9, 2001
The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemiaK Lee, P Gane, F Roudot-Thoraval, et al.
Blood|January 1, 1985
The heterozygous form of 4.1(-) hereditary elliptocytosis [the 4.1(-) trait]N Alloisio, L Morlé, E Dorléac, et al.
Pageof 7